Introduction Semaglutide, A medication initially developed for the treatment of type 2 diabetes, has emerged as a breakthrough in managing obesity and improving cardiovascular health. As a member of the GLP-1 receptor agonist class, Semaglutide mimics a natural hormone in the body that helps regulate blood sugar, suppress appetite, and https://finnboajs.blogspothub.com/30845857/semaglutide-transforming-the-landscape-of-diabetes-and-weight-management